Chargement en cours...
Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure
Antiviral resistance is now the single most important factor in treatment failure using nucleos(t)ide analogues (NA). Primary drug resistance mutations refer to amino acid change(s) that result in reduced susceptibility to an antiviral agent. Secondary compensatory mutations restore replication defe...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer-Verlag
2008
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2716855/ https://ncbi.nlm.nih.gov/pubmed/19669299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-008-9048-3 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|